Oct 30 ( Reuters ) - Danish drugmaker Novo Nordisk has made a higher offer for Metsera seeking to trump an agreed deal with Pfizer so it can consolidate its position in weight-loss medications, Bloomberg News reported on Thursday citing people with knowledge of the matter.

Novo Nordisk, which had earlier made a takeover proposal for Metsera before the US company reached a deal with Pfizer, has come back with another offer with an improved value and structure, the people said. Metsera and Novo Nordisk are in advanced discussions on the sweetened bid and could reach an agreement on a potential deal as soon as Thursday, the people said.

Metsera shares jumped 18.6% in premarket trading.